Romanian drug manufacturer Antibiotice Iasi has proposed the distribution of RON13.8 million worth of dividends from the 2024 net profit reported on the basis of annual audited financial statements, namely RON102.2 million.
Home ownership remains a major objective for most Romanians, but the increasingly dwindling affordability in central areas and strict lending conditions led to a decline in home buying intentions in 2025, stated Gabriel Blanita, Director & Advisory Services at Colliers Romania.